ClinicalTrials.gg
RecruitingNCT06367608FUS DystoniaUpdated Feb 27, 2026

MRgFUS Pallidotomy for the Treatment of Task Specific Focal Hand Dystonia (TSFD)

An interventional study of ExAblate Transcranial treatment in Task-Specific Focal Dystonia, sponsored by University of Maryland, Baltimore. Recruiting at 1 site in United States. Open to participants aged 21 Years to 75 Years. Per ClinicalTrials.gov, last updated 2026-02-27.

Sponsored by University of Maryland, Baltimore · Not applicable, Interventional, and Device feasibility

How we know

From the registry’s dates

  • Started Jun 2024; still recruiting 2 years 5 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
10
Allocation
Not applicable
Ages
21 Years to 75 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 21 studies in Dystonia, Focal, Task-Specific with a site in United States — 1 open to participants now, 3 under way, none of them phase 3. Dystonia, Focal, Task-Specific · United States.

Started
2024
the only one that year
No phase
3 of 21
1 open now
Registered
20th of 21
by date
Lead sponsor
1 of 21
University of Maryland, Baltimore

Among the 21 studies in Dystonia, Focal, Task-Specific with a site in United States, this one is the only one that started in 2024, is one of 3 with no phase, and was the 20th registered.

Dystonia, Focal, Task-Specific

26 studies on the registry are indexed under Dystonia, Focal, Task-Specific; 3 are open to participants now.

Browse Dystonia, Focal, Task-Specific studies →

Open to participants now

1 of the 21 studies in Dystonia, Focal, Task-Specific with a site in United States is open now.

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 2 Dystonia, Focal, Task-Specific studies recruiting now, 1 sets no upper age limit and 1 stops at 75 or younger; none take children under 18; none take healthy volunteers.

This study: 21 Years to 75 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 21 studies in Dystonia, Focal, Task-Specific with a site in United States, or all of them as a file.
02

Study summary

The purpose of this study is to assess the safety and effectiveness of MRI-guided focused ultrasound (MRgFUS) for treating task specific focal hand dystonias (TSFD). TSFD is a type of dystonia that affects hand movements during specific tasks such as writing, playing instruments or typing, often causing involuntarily movements or cramping.

Read the detailed description

The purpose of this study is to assess the safety and effectiveness of MRI-guided focused ultrasound (MRgFUS) for treating task specific focal hand dystonias (TSFD). TSFD refers to a condition where certain movements or tasks trigger involuntary muscle contractions, particularly during specialized and repetitive activities like writing (known as writer's dystonia), typing (typist's dystonia), playing musical instruments (musician's dystonia), or engaging in sports like golf, table tennis, or juggling. While TSFD affects around 1.2-1.5% of the general population, it's more common among athletes and musicians. Writer's dystonia, for example, typically starts with difficulty writing and hand cramping in the dominant hand, possibly spreading to the arm and shoulder muscles over time. In severe cases, the other hand may also be affected. Similarly, typist's dystonia can lead to finger flexion or extension issues during typing. Musician's dystonia is another form, seen in guitarists, pianists, harpists, or flute players, often emerging during the peak of their careers and significantly impacting musical performance. These dystonias can be career-ending as they impair performance and rarely go into remission, with onset often occurring around the age of forty.

Surgical treatments for Task-Specific Focal Dystonia (TSFD) are less often explored than for other dystonias. Thalamotomy, targeting the ventro-oralis (Vo) nucleus, has shown some promise for hand dystonias like writer's cramp or musician's dystonia. Anecdotally, some benefit from deep brain stimulation (DBS) targeting the globus pallidus internus (GPi) has also been shown, but large-scale studies for TSFD are lacking.

Another promising approach is MR guided focused ultrasound thalamotomy, a non-invasive procedure that uses real-time imaging to precisely target brain areas. This method has already shown success in treating essential tremors and Parkinson's disease symptoms. Recent studies and anecdotal cases have also demonstrated its potential for treating TSFD, with improvements in symptoms observed in patients with writer's cramp, musician's dystonia, and other related conditions.

The Exablate MR Guided Focused Ultrasound Transcranial system is a device designed to overcome the limitations of delivering ultrasound through the intact skull. It uses advanced technology like water-cooling, acoustic correction algorithms, and patient-specific CT data to ensure precise and safe delivery of ultrasound energy to targeted brain areas. This pilot study protocol aims to utilize MR guided focused ultrasound thalamotomy as a treatment option for TSFD.

03

Conditions studied

  • Task-Specific Focal Dystonia
04

Who can participate

Ages eligible
21 Years to 75 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Clinical diagnosis of moderate to severe TSFD with impact in their daily function or occupation function
  2. Patients who failed to response or had unsatisfactory response to the first treatment, such as Botulinum toxin treatment or DBS or refuse these alternative options
  3. Age greater than 21 and less than 75 years
  4. Subjects who are able and willing to give consent and able to attend all study visits,
  5. Documented chronic, symptoms for more than 6 months duration
  6. Pallidotomy is feasible based on evaluation of imaging studies
  7. Patient able to communicate sensations during the ExAblate TcMRgFUS treatment
  8. Two members of the medical team have agreed upon inclusion and exclusion criteria

Exclusion criteria

Exclusion Criteria:

  1. Patient with to MRI such as severe claustrophobia and metallic implants incompatible with MRI.
  2. Presence of generalized dystonia or involvement of two or more contiguous body regions (such as Arm along with neck)
  3. Severe psychiatric disorder such as uncontrolled depression, anxiety, bipolar disorder, prior attempt at suicide or suicide ideation in preceding 12 months
  4. less than 12 months
  5. Anticoagulant or antiplatelet medications as well as underlying coagulopathy
  6. Pregnant ladies or women of childbearing age who are sexually active and not using
  7. Inability to provide , for example due to underlying cognitive impairment or aphasia
  8. Presence of intracranial mass or an acute intracranial abnormality
  9. Subjects with unstable cardiac status such as unstable angina pectoris, documented myocardial infarction within 6 months of protocol entry or less than 40
  10. Subjects exhibiting any behavior(s) consistent with ethanol or substance abuse as defined by the criteria outlined in the (DSM-IV)
  11. Severe hypertension (diastolic blood pressure > 100 on medication or persistently elevated systolic blood pressure>140 mmHg despite adequate antihypertensive medications)
  12. History of intracranial hemorrhage, traumatic brain injury or thalamic stroke.
  13. Cerebrovascular disease (multiple cerebrovascular accident's (CVA) or CVA within 6 months)
  14. Subjects with life-threatening systemic disease that include and not limited to the following will be excluded from the study participation: , Liver Failure, blood dyscrasias, etc.
  15. Subjects with a history of seizures within the past year
  16. Individuals who are not able or willing to tolerate the required prolonged stationary supine position during treatment (can be up to 4 hours of total table time.)

    -

Terms in these criteria, in plain language(7)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

Life expectancy

The study doctor’s estimate of how long someone is likely to live. Criteria use it so that people can stay in the study long enough for it to answer its question.

Contraception

Ways of preventing pregnancy. “Highly effective” methods fail less than 1% of the time a year when used correctly — for example an IUD or an implant.

Criteria usually say which methods count and how long to keep using them after the last dose, sometimes for male participants too. Some studies accept a partner’s vasectomy if it was confirmed successful and that person is the participant’s only sexual partner.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

LVEF (left ventricular ejection fraction)

The share of blood the heart’s main pumping chamber (the left ventricle) pushes out with each beat, measured by an echocardiogram (heart ultrasound) or a MUGA scan. About 50–70% is normal.

DSM diagnostic criteria

The American Psychiatric Association’s manual of mental health diagnoses. DSM-5 (2013, revised as DSM-5-TR in 2022) replaced DSM-IV, and some studies still name the older edition. “Meets DSM criteria for …” means diagnosed by that edition’s diagnostic criteria, usually by a clinician in an interview.

HIV

The human immunodeficiency virus, which weakens the immune system.

Many studies now accept people whose HIV is controlled on treatment, judged by the viral load and the CD4 count. Check the limits this study sets.

05

Study design

Phase
Not applicable
Primary purpose
Device feasibility
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
10 participants (estimated)

Study arms

  • Experimental
    ExAblate Transcranial treatment

    The ExAblate Transcranial system will be used to destroy a small cluster of cells that may be causing the study participant's pain . The ExAblate uses ultrasound to heat a small spot in the brain called globus pallidus internus(GPi). Ultrasound passes through the skin and skull and into the brain to focus on this particular spot.

    Device: ExAblate Transcranial treatment

Interventions

  • DeviceExAblate Transcranial treatment

    The ExAblate Transcranial system will be used to destroy a small cluster of cells that may be causing the study participant's dystonia . The ExAblate uses ultrasound to heat a small spot in the brain called globus pallidus internus(GPi). Ultrasound passes through the skin and skull and into the brain to focus on this particular spot.

    Also known as: The ExAblate® MR guided focused ultrasound system

06

What researchers measure

Primary outcomes

  1. Incidence of Treatment related adverse events

    Procedure related or device related adverse events will be reported, from the treatment day through the 6-month follow-up period.

    Time frame: All events will be reported up to 6 months from treatment

Secondary outcomes

  1. Change in dystonia intensity

    Efficacy of ExAblate TcMRgFUS for pallidotomy will be evaluated using Arm disability dystonia scale (ADDS) and scales specific to writer's cramp (WCRS) or musician's dystonia (TMDS) scores.

    Time frame: 6 Months

  2. Change in patient's perception of quality of life

    Quality of life assessments will be performed with short form (SF)-36 survey

    Time frame: 6 months

  3. Change in patient's perception of the effect of the procedure

    Patient Global impression of change (PGIC): The effect of the procedure on patient perceived impact of pain related symptoms, emotions and quality of life will be measured using PGIC scale.

    Time frame: 6 Months

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Jun 2024 (actual). Primary completion is estimated for Jun 2027, 36 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Apr 11, 2024
First posted
Apr 16, 2024
StartActual
Jun 10, 2024
Primary completionEst.
Jun 2027
CompletionEst.
Jun 2028
Last update
Feb 27, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Feb 27, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06367608
Collaborators
Focused Ultrasound Foundation, InSightec
Responsible party
Sponsor
First posted
Apr 16, 2024
Start date
Jun 10, 2024
Primary completion
Jun 2027 (estimated)
Completion
Jun 2028 (estimated)
Last update
Feb 27, 2026

Study contacts

Dheeraj Gandhi, MD
Contact
dgandhi@umm.edu
(248)-497-8856
Najme Hosseini
Contact
NHosseini@som.umaryland.edu
410-328-4068

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion